Basel, Switzerland

Arndt Meyer

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Novartis Ag. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arndt Meyer. Retrieved from https://idiyas.com/inventor/arndt-meyer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arndt Meyer: Innovator in Medicinal Chemistry

Introduction

Arndt Meyer is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on heteroaryl-fused pyridines. His research has implications for the development of new medicaments.

Latest Patents

Arndt Meyer holds a patent for "Disubstituted heteroaryl-fused pyridines." This invention relates to a compound of the formula (I'), where the substituents are defined in the specification. The compound can exist in free form or as a salt. The patent also covers its preparation, use as a medicament, and medicaments that comprise it. He has 1 patent to his name.

Career Highlights

Meyer is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to focus on the development of innovative therapeutic solutions. His expertise in medicinal chemistry has been instrumental in advancing the company's research initiatives.

Collaborations

Throughout his career, Arndt Meyer has collaborated with talented professionals, including Sangamesh Badiger and Dirk Behnke. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Arndt Meyer is a distinguished inventor whose work in medicinal chemistry continues to impact the development of new treatments. His contributions, particularly in the area of heteroaryl-fused pyridines, highlight the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…